CERO THERAPEUTICS HOLDINGS, INC. (CERO)
Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014Q1-CY2014Q4-CY2013
Balance Sheet Date2025-Sep-302025-Jun-302025-Mar-312024-Dec-312023-Dec-31
Fiscal PeriodQ3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q4-FY2023
Total Assets3,911,394$6,202,322$7,991,414$6,206,929$6,491,997$7,370,765$9,052,656$5,126,302$42,367,032$
Total Current Assets2,553,899$4,246,566$5,768,001$3,714,041$3,714,483$4,245,911$5,501,205$1,970,035$
Cash and Cash Equivalents1,900,000$3,200,000$5,100,000$96,873$475,870$
Receivables
Other Current Assets
Assets Held for Sale in Short Term
Total Noncurrent Assets1,357,495$1,955,756$2,223,413$2,492,888$2,777,514$3,124,854$3,551,451$3,156,267$42,367,032$
Goodwill
Other Intangible Assets
Physical Assets313,452$382,806$452,227$528,521$624,900$738,755$853,059$966,702$
Other Noncurrent Assets
Assets Held for Sale in Long Term
Total Liabilities8,454,556$7,836,223$8,320,800$8,101,492$10,194,422$9,852,633$13,031,753$5,082,653$39,898,341$
Total Current Liabilities8,454,556$7,617,915$7,859,220$7,402,385$9,422,897$8,779,323$11,651,445$3,507,154$30,748,341$
Accounts Payable7,077,342$6,213,045$6,379,056$4,507,318$6,667,073$6,347,348$7,059,695$1,671,745$
Short Term Debt
Short Term Capital Lease Obligations931,023$934,310$905,005$876,392$931,023$821,318$794,893$769,092$
Other Current Liabilities40,000$593,825$31,071$25,601$92,875$1,833$
Total Noncurrent Liabilities0$218,308$461,580$699,107$771,525$1,073,310$1,380,308$1,575,499$9,150,000$
Long Term Debt
Long Term Capital Lease Obligations218,308$461,580$699,107$771,525$1,073,310$1,366,585$1,575,499$
Other Noncurrent Liabilities
Total Equity(4,543,162$)(1,633,901$)(329,386$)(1,894,563$)(3,702,425$)(2,481,868$)(3,979,097$)(42,057,695$)(11,000,154$)
Equity to Minority
Equity to Common Shareholders(4,543,162$)(1,633,901$)(329,386$)(1,894,563$)(3,702,425$)(2,481,868$)(3,979,097$)(42,057,695$)(11,000,154$)
Additional Paid-In Capital73,055,709$71,311,399$73,345,026$67,142,276$66,363,448$57,632,881$53,994,723$1,032,125$
Retained Earnings(86,297,494$)(81,441,099$)(76,023,784$)(70,917,853$)(71,589,745$)(67,361,778$)(64,913,124$)(43,089,821$)(11,000,701$)
Treasury Stock
Capital Lease Obligations931,023$1,152,618$1,366,585$1,575,499$1,702,548$1,894,628$2,161,478$2,344,591$